VR
Veraxa Biotech Holding AG
VRXA · NASDAQ
$1.48 -1.66% (-$0.03)
1M -17.98%
Valuation
-
N/A P/FCF N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
-
N/A ROE N/A
ROA N/A
Asset turnover N/A
Debt
-
N/A Debt/Assets N/A
Int. coverage N/A
Net debt/EBITDA N/A
Stability
15 /100
Unstable Beta 0.26x
EPS volatility N/A
Profitable years N/A
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about VRXA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christoph Antz
Employees
8
Headquarters
Heidelberg